Sector
PharmaceuticalsOpen
₹208Prev. Close
₹205.92Turnover(Lac.)
₹535.37Day's High
₹212Day's Low
₹205.0552 Week's High
₹245.752 Week's Low
₹148.5Book Value
₹67.56Face Value
₹5Mkt Cap (₹ Cr.)
1,041.08P/E
21.94EPS
9.45Divi. Yield
0.7217 May 2024
12:00 AM
Dividend
Dividend Amount: 2.5
Record Date: 16 Aug, 2024
17 May 2024
12:00 AM
AGM
Announcement Date: 17 May, 2024
19 May 2025
12:00 AM
Board Meeting
Agenda : Audited Result
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 25.06 | 25.06 | 25.06 | 25.06 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 266.16 | 216.17 | 188.72 | 165.59 |
Net Worth | 291.22 | 241.23 | 213.78 | 190.65 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 431.96 | 306.95 | 238.07 | 206.14 |
yoy growth (%) | 40.72 | 28.93 | 15.48 | -36.8 |
Raw materials | -329.79 | -230.16 | -180.79 | -150.61 |
As % of sales | 76.34 | 74.98 | 75.93 | 73.06 |
Employee costs | -14.29 | -13.36 | -9 | -7.21 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 38.55 | 19.15 | 23.41 | 27.58 |
Depreciation | -15.07 | -7.03 | -1.83 | -1.96 |
Tax paid | -10.11 | -4.85 | -6.9 | -7.53 |
Working capital | 61.47 | -22.96 | 11.14 | -7.43 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 40.72 | 28.93 | 15.48 | -36.8 |
Op profit growth | 95.81 | 27.2 | -18.66 | -40.08 |
EBIT growth | 100.75 | -14.96 | -15.1 | -27.25 |
Net profit growth | 98.78 | -13.36 | -17.64 | -22.29 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,672 | 93.86 | 4,01,288.77 | 2,000.46 | 0.96 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,835 | 82.12 | 1,81,397.34 | 667 | 0.44 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,485 | 24.92 | 1,19,948.65 | 1,485.4 | 1.08 | 4,254.47 | 397.41 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,314.2 | 59.26 | 1,12,127.01 | 474 | 0.18 | 2,385 | 224.34 |
Mankind Pharma Ltd MANKIND | 2,578.3 | 56.47 | 1,06,401.47 | 382.46 | 0 | 2,126.59 | 354.71 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Vice Chairman
Bipin N Shah
Non-Exec & Non-Independent Dir
Bharat N Shah
Chairman (Non-Executive)
Arun L Todarwal
Non-Exec & Non-Independent Dir
Samir J Shah
Non-Exec & Non-Independent Dir
Ketan L Shah
Joint Managing Director
Ritesh B Shah
Joint Managing Director
Vivek B Shah
Non-Exec & Non-Independent Dir
Mita Dixit
Non-Exec. & Independent Dir.
Harmanbhai Tulsibhai Patel
Independent Director
Pradeep Thakur
Independent Director
Siddharth Shah
Non-Exec & Non-Independent Dir
Gaurav Shah
Company Sec. & Compli. Officer
Manan Jayesh Vadhan
3-A Shivsagar Estate,
North Wing Dr A B Road Worli,
Maharashtra - 400018
Tel: 91-22-6622 7575
Website: http://www.anuhpharma.com
Email: anuh@sk1932.com
J/12 Ansa Indl Est,
Sakivihar Road, Sakinaka Andheri (E),
Mumbai - 400072
Tel: 91-22-8524914/852354
Website: www.bigshareonline.com
Email: marketing@bigshareonline.com
Summary
Anuh Pharma Limited is one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs). The Company is engaged in the business of manufacturing and selling of Bulk drugs and chemicals. Th...
Read More
Reports by Anuh Pharma Ltd
What is the Anuh Pharma Ltd share price today?
What is the Market Cap of Anuh Pharma Ltd?
What is the PE and PB ratio of Anuh Pharma Ltd?
What is the 52 Week High and Low of Anuh Pharma Ltd?
What is the CAGR of Anuh Pharma Ltd?
What is the shareholding pattern of Anuh Pharma Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.